Literature DB >> 26719605

Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review.

Aaron W James1, Le Chang1, Scott Genshaft2, Sarah M Dry1.   

Abstract

Neurofibromatosis type 1 (NF1) is associated with increased risk of multiple neoplasms. We present a case of a female patient with NF1 who presented with a rectal low-grade neuroendocrine (carcinoid) tumor. Computed tomography imaging found a well-differentiated liposarcoma and a well-circumscribed gastro-intestinal stromal tumor (GIST). Although GIST and carcinoid tumors are frequently found in NF1 patients, liposarcoma complicating NF1 is quite rare and this is the first reported case of well-differentiated liposarcoma in NF1. In summary, we report a case of coincident abdominal carcinoid tumor, GIST and well-differentiated liposarcoma, which illustrates the variability of neoplasms in NF1 patients.

Entities:  

Keywords:  Carcinoid; GIST; Malignant peripheral nerve sheath tumor; Type 1 neurofibromatosis; Well-differentiated liposarcoma

Year:  2014        PMID: 26719605      PMCID: PMC4674501          DOI: 10.1016/j.jor.2014.08.010

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  43 in total

1.  Simultaneous occurrence of von Recklinghausen's neurofibromatosis and osteitis fibrosa cystica; report of a case showing both diseases in addition to liposarcoma.

Authors:  D H CLARK; W R MATHEWS
Journal:  Surgery       Date:  1953-03       Impact factor: 3.982

2.  Omental liposarcoma; a rare complication in neurofibromatosis type 1.

Authors:  A Imai; K Onogi; Y Sugiyama
Journal:  J Obstet Gynaecol       Date:  2006-05       Impact factor: 1.246

3.  Multiple rectal carcinoids in a patient with neurofibromatosis.

Authors:  Kevin A Ghassemi; Honzen Ou; Bennett E Roth
Journal:  Gastrointest Endosc       Date:  2010-01       Impact factor: 9.427

4.  Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors.

Authors:  H R Makhlouf; A P Burke; L H Sobin
Journal:  Cancer       Date:  1999-03-15       Impact factor: 6.860

5.  The genetic aspects of neurofibromatosis.

Authors:  J C Carey; B J Baty; J P Johnson; T Morrison; M Skolnick; J Kivlin
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

6.  Neurofibromatosis with gastrointestinal stromal tumors: insights into the association.

Authors:  Shih-Ping Cheng; Ming-Jer Huang; Tsen-Long Yang; Chin-Yuan Tzen; Chien-Liang Liu; Tsang-Pai Liu; Shu-Ching Hsiao
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Authors:  D F Easton; M A Ponder; S M Huson; B A Ponder
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

Review 8.  Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease).

Authors:  C E Fuller; G T Williams
Journal:  Histopathology       Date:  1991-07       Impact factor: 5.087

9.  Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).

Authors:  J Szudek; H Joe; J M Friedman
Journal:  Genet Epidemiol       Date:  2002-08       Impact factor: 2.135

10.  A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

Authors:  L Walker; D Thompson; D Easton; B Ponder; M Ponder; I Frayling; D Baralle
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

View more
  8 in total

1.  Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma.

Authors:  Eric E Jung; F Scott Heinemann; Colt A Egelston; Jennifer Wang; Raphael E Pollock; Peter P Lee; William W Tseng
Journal:  BMJ Case Rep       Date:  2019-05-13

2.  Recommendation of long-term and systemic management according to the risk factors in rectal NETs patients.

Authors:  Motohiro Kojima; Yu Chen; Koji Ikeda; Yuichiro Tsukada; Daigoro Takahashi; Shingo Kawano; Kota Amemiya; Masaaki Ito; Rieko Ohki; Atsushi Ochiai
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

3.  Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.

Authors:  Jace P Landry; Kelsey L Schertz; Yi-Ju Chiang; Angela D Bhalla; Min Yi; Emily Z Keung; Christopher P Scally; Barry W Feig; Kelly K Hunt; Christina L Roland; Ashleigh Guadagnolo; Andrew J Bishop; Alexander J Lazar; John M Slopis; Ian E McCutcheon; Keila E Torres
Journal:  JAMA Netw Open       Date:  2021-03-01

Review 4.  Gastrointestinal Stromal Tumor (GIST) and Synchronous Intra-Abdominal Liposarcoma: A Report of Two Rare Cases and Literature Review.

Authors:  Alexandros Diamantis; Athina A Samara; Ioannis Baloyiannis; Dimitrios Symeonidis; Andreas-Marios Diamantis; Maria Tolia; Konstantinos Bouliaris; Georgios Koukoulis; Konstantinos Tepetes
Journal:  Int J Surg Oncol       Date:  2021-09-01

5.  A Rare Case of the Coexistence of Pancreaticobiliary Maljunction and Gastrointestinal Tumor in Neurofibromatosis Type 1.

Authors:  Rie Tanaka; Akinori Sekioka; Shuichi Ota; Tetsuo Ito; Yukito Adachi
Journal:  Cureus       Date:  2022-04-11

6.  Rare triad of periampullary carcinoid, duodenal gastrointestinal stromal tumor and plexiform neurofibroma at hepatic hilum in neurofibromatosis type 1: a case report.

Authors:  Nihed Abdessayed; Rahul Gupta; Sarra Mestiri; Ahlem Bdioui; Mounir Trimech; Moncef Mokni
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

Review 7.  Spectrum of gastrointestinal lesions of neurofibromatosis type 1: a pictorial review.

Authors:  Nada Garrouche; Amel Ben Abdallah; Nadia Arifa; Ibtissem Hasni; Yasser Ben Cheikh; Waad Ben Farhat; Sana Ben Amor; Hela Jemni
Journal:  Insights Imaging       Date:  2018-09-04

8.  Coexistence of gastric gastrointestinal stromal tumor, intro-abdominal and retroperitoneal liposarcomas -a case report.

Authors:  Yong Zhou; Xu-Dong Wu; Quan Shi; Chuan-Hai Xu; Jing Jia
Journal:  BMC Cancer       Date:  2018-10-11       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.